Amarin Corp. Plc (AMRN)
13.90
+0.02
(+0.14%)
USD |
NASDAQ |
Sep 01, 14:54
Amarin Total Long Term Debt (Quarterly) : 5.255M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.255M |
| March 31, 2026 | 5.585M |
| December 31, 2025 | 6.08M |
| September 30, 2025 | 6.731M |
| June 30, 2025 | 7.338M |
| March 31, 2025 | 7.94M |
| December 31, 2024 | 7.723M |
| September 30, 2024 | 8.215M |
| June 30, 2024 | 8.099M |
| March 31, 2024 | 8.389M |
| December 31, 2023 | 8.737M |
| September 30, 2023 | 8.97M |
| June 30, 2023 | 9.472M |
| March 31, 2023 | 9.841M |
| December 31, 2022 | 10.02M |
| September 30, 2022 | 9.924M |
| June 30, 2022 | 10.17M |
| March 31, 2022 | 10.40M |
| December 31, 2021 | 8.576M |
| September 30, 2021 | 8.729M |
| June 30, 2021 | 8.875M |
| March 31, 2021 | 9.015M |
| December 31, 2020 | 9.153M |
| September 30, 2020 | 18.72M |
| June 30, 2020 | 31.77M |
| Date | Value |
|---|---|
| March 31, 2020 | 46.36M |
| December 31, 2019 | 59.57M |
| September 30, 2019 | 69.48M |
| June 30, 2019 | 76.77M |
| March 31, 2019 | 82.23M |
| December 31, 2018 | 80.35M |
| September 30, 2018 | 113.43M |
| June 30, 2018 | 117.02M |
| March 31, 2018 | 119.12M |
| December 31, 2017 | 122.66M |
| September 30, 2017 | 124.91M |
| June 30, 2017 | 127.38M |
| March 31, 2017 | 99.70M |
| December 31, 2016 | 117.68M |
| September 30, 2016 | 117.49M |
| June 30, 2016 | 124.58M |
| March 31, 2016 | 252.87M |
| December 31, 2015 | 253.03M |
| September 30, 2015 | 238.04M |
| June 30, 2015 | 237.26M |
| March 31, 2015 | 104.18M |
| December 31, 2014 | 234.26M |
| September 30, 2014 | 226.79M |
| June 30, 2014 | 217.27M |
| March 31, 2014 | 245.81M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 401.80M |
| Alkermes Plc | 1.565B |
| Cellectis SA | 96.78M |
| Akari Therapeutics Plc | 0.00 |
| Liquidia Corp. | 182.90M |